HMGB1 and systemic lupus erythematosus: To elucidate this discrepancy, we examined the efficacy of anti-HMGB1 mAb to determine whether it ameliorates lupus activities, including nephritis and serological abnormalities, in MRL/lpr lupus-prone mice.